[摘 要]目的 评价重组人红细胞生成素(rhEP0)治疗肿瘤放疗相关性贫血的疗效和安全性。方法 放疗相关性贫血患者50例，其中治疗组25例给予rhEPO治疗，疗程8周；对照组25例未用rhEP0治疗。观察rhEPO对血红蛋白(Hb)及对患者生存质量(QOF)的影响。结果 治疗组治疗后Hb水平显著提高，治疗组与对照组相比生活质量明显提高。结论 rhEP0治疗肿瘤放疗相关性贫血的疗效肯定，安全性高，能够改善患者生存质量。

    关键词：恶性肿瘤贫血 重组人红细胞生成素 血红蛋白

    Study of erythropoietin in treating the cancer-Related anemia after radiotherapy

    Jin Cai-ling， MIAO Zhan-hui(Department of Medical Oncolgy，the First Affiliated Hospital of Xinxiang Medical College，Weihui)

    [Absract] Objective To observe the effect of recombinant human erythropoietin(rhEPO)in cancer-related anemia after radiotherapy.Methods 50 patients diagnosized anemia were divided into experiment group and control group. rhEPO intramuscular was conduced on patients in experiment group within eight weeks.The control group was treated with support cares.The influence of rhEPO on Hb and quantity of 1ife were observed.Result rhEPO is the most effective to treatment of cancer-related anemia and can greatly improve Hb level.The QOF were higher than that of control group. Conclusion rhEPO is effective and safe in treating cancer related anemia.It can improve the sufferer existence quantity. ......